CY1112218T1 - Νεα παραγωγα ανταγωνιστες υποδοχεα βιτρονεκτινης, μεθοδος παρασκευης τους, η εφαρμογη τους ως φαρμακα και φαρμακευτικες συνθεσεις που τα περιεχουν - Google Patents
Νεα παραγωγα ανταγωνιστες υποδοχεα βιτρονεκτινης, μεθοδος παρασκευης τους, η εφαρμογη τους ως φαρμακα και φαρμακευτικες συνθεσεις που τα περιεχουνInfo
- Publication number
- CY1112218T1 CY1112218T1 CY20111101051T CY111101051T CY1112218T1 CY 1112218 T1 CY1112218 T1 CY 1112218T1 CY 20111101051 T CY20111101051 T CY 20111101051T CY 111101051 T CY111101051 T CY 111101051T CY 1112218 T1 CY1112218 T1 CY 1112218T1
- Authority
- CY
- Cyprus
- Prior art keywords
- preparation
- vitronectine
- competitive
- receptors
- medicinal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Η ευρεσιτεχνία έχει ως αντικείμενο ενώσεις του τύπου (Ι) στον οποίο τα R1, R2, R3, R4 και G είναι όπως ορίζεται στην περιγραφή, τη μέθοδο παρασκευής τους, τη χρήση τους ως φάρμακα που έχουν δράση ανταγωνιστή υποδοχέα βιτρονεκτίνης και φαρμακευτικές συνθέσεις που τις περιέχουν.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0214429A FR2847254B1 (fr) | 2002-11-19 | 2002-11-19 | Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant |
EP09003174A EP2070914B1 (fr) | 2002-11-19 | 2003-11-12 | Nouveaux dérivés antagonistes du récepteur de la vitronectine, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112218T1 true CY1112218T1 (el) | 2015-12-09 |
Family
ID=32187700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111101051T CY1112218T1 (el) | 2002-11-19 | 2011-11-02 | Νεα παραγωγα ανταγωνιστες υποδοχεα βιτρονεκτινης, μεθοδος παρασκευης τους, η εφαρμογη τους ως φαρμακα και φαρμακευτικες συνθεσεις που τα περιεχουν |
Country Status (28)
Country | Link |
---|---|
US (2) | US7582640B2 (el) |
EP (2) | EP1565467B1 (el) |
JP (1) | JP4567459B2 (el) |
KR (1) | KR101140752B1 (el) |
CN (2) | CN101928287A (el) |
AR (2) | AR042068A1 (el) |
AT (2) | ATE518842T1 (el) |
AU (2) | AU2003299330B2 (el) |
BR (1) | BR0316307A (el) |
CA (1) | CA2506310C (el) |
CO (1) | CO5700761A2 (el) |
CY (1) | CY1112218T1 (el) |
DE (1) | DE60327712D1 (el) |
DK (2) | DK1565467T3 (el) |
ES (2) | ES2369561T3 (el) |
FR (1) | FR2847254B1 (el) |
HK (2) | HK1076277A1 (el) |
IL (2) | IL168136A (el) |
MA (1) | MA27492A1 (el) |
MX (1) | MXPA05005340A (el) |
NO (1) | NO20052491D0 (el) |
PL (1) | PL376866A1 (el) |
PT (2) | PT1565467E (el) |
RU (1) | RU2412185C2 (el) |
SI (2) | SI1565467T1 (el) |
TW (1) | TW200412969A (el) |
WO (1) | WO2004048375A1 (el) |
ZA (1) | ZA200502850B (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2847254B1 (fr) | 2002-11-19 | 2005-01-28 | Aventis Pharma Sa | Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant |
FR2870541B1 (fr) * | 2004-05-18 | 2006-07-14 | Proskelia Sas | Derives de pyrimidines antigonistes du recepteur de la vitronectine |
US20110189174A1 (en) | 2010-02-01 | 2011-08-04 | Afshin Shafiee | Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization |
US20110237605A1 (en) | 2010-03-26 | 2011-09-29 | Eric Phillips | Molecular Crystal of (4-(1,8-Naphthyridin-2-YL)Piperidin-1-YL)Pyrimidine Derivative |
ES2836733T3 (es) | 2018-08-17 | 2021-06-28 | Oxurion NV | Antagonistas de integrina |
WO2021165206A1 (en) | 2020-02-19 | 2021-08-26 | Oxurion NV | Treatment of dry amd with integrin antagonists |
EP4171212A1 (en) | 2020-06-29 | 2023-05-03 | Ickovic & Bliss, Inc. | Systems, methods, and program products for digital pet identification |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5204350A (en) | 1991-08-09 | 1993-04-20 | Merck & Co., Inc. | Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives |
US5217994A (en) | 1991-08-09 | 1993-06-08 | Merck & Co., Inc. | Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives |
US5786373A (en) | 1992-10-14 | 1998-07-28 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
WO1994012181A1 (en) | 1992-12-01 | 1994-06-09 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
AU701776B2 (en) | 1994-05-27 | 1999-02-04 | Merck & Co., Inc. | Compounds for inhibiting osteoclast-mediated bone resorption |
JPH10504807A (ja) * | 1994-06-29 | 1998-05-12 | スミスクライン・ビーチャム・コーポレイション | ビトロネクチン受容体拮抗剤 |
MX9700041A (es) | 1994-06-29 | 1997-04-30 | Smithkline Beecham Corp | Antagonistas de receptor de vitronectina. |
EP0907637A1 (de) | 1996-06-28 | 1999-04-14 | MERCK PATENT GmbH | Phenylalanin-derivate als integrin-inhibitoren |
DE19629816A1 (de) * | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
US6723727B1 (en) | 1996-12-20 | 2004-04-20 | Hoechst Aktiengesellschaft | Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
DE19653646A1 (de) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung |
EP0933367A1 (en) * | 1997-12-19 | 1999-08-04 | Hoechst Marion Roussel Deutschland GmbH | Novel acylguanidine derivates as inhibitors of bone resorption and as vitronectin receptor antagonists |
NZ505613A (en) | 1998-01-23 | 2002-11-26 | Aventis Pharma Gmbh | Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
WO1999050249A2 (en) * | 1998-04-01 | 1999-10-07 | Du Pont Pharmaceuticals Company | Pyrimidines and triazines as integrin antagonists |
HUP0103090A3 (en) * | 1998-08-07 | 2002-12-28 | Smithkline Beecham Corp | Vitronectin receptor antagonist oxazole derivatives, process for their preparation, pharmaceutical compositions containing them and their use |
EP1194151A4 (en) | 1999-06-23 | 2003-01-15 | Merck & Co Inc | ANTAGONISTS OF THE INTEGRIN RECEPTORS |
EP1065208A1 (en) * | 1999-07-02 | 2001-01-03 | Aventis Pharma Deutschland GmbH | Substituted purine derivatives as inhibitors of cell adhesion |
EP1065207A1 (en) | 1999-07-02 | 2001-01-03 | Aventis Pharma Deutschland GmbH | Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them |
US6676750B1 (en) * | 1999-10-05 | 2004-01-13 | Geoffrey John Davies | Growth of diamond clusters |
DE10042655A1 (de) * | 2000-08-31 | 2002-03-14 | Aventis Pharma Gmbh | Verfahren zur Herstellung von Inhibitoren der Zell-Adhäsion |
FR2847254B1 (fr) | 2002-11-19 | 2005-01-28 | Aventis Pharma Sa | Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant |
FR2870541B1 (fr) * | 2004-05-18 | 2006-07-14 | Proskelia Sas | Derives de pyrimidines antigonistes du recepteur de la vitronectine |
-
2002
- 2002-11-19 FR FR0214429A patent/FR2847254B1/fr not_active Expired - Fee Related
-
2003
- 2003-11-12 MX MXPA05005340A patent/MXPA05005340A/es active IP Right Grant
- 2003-11-12 EP EP03799611A patent/EP1565467B1/fr not_active Expired - Lifetime
- 2003-11-12 AT AT09003174T patent/ATE518842T1/de active
- 2003-11-12 CN CN2009101705723A patent/CN101928287A/zh active Pending
- 2003-11-12 PT PT03799611T patent/PT1565467E/pt unknown
- 2003-11-12 AT AT03799611T patent/ATE431825T1/de active
- 2003-11-12 PT PT09003174T patent/PT2070914E/pt unknown
- 2003-11-12 PL PL376866A patent/PL376866A1/pl not_active Application Discontinuation
- 2003-11-12 ES ES09003174T patent/ES2369561T3/es not_active Expired - Lifetime
- 2003-11-12 SI SI200331636T patent/SI1565467T1/sl unknown
- 2003-11-12 DK DK03799611T patent/DK1565467T3/da active
- 2003-11-12 EP EP09003174A patent/EP2070914B1/fr not_active Expired - Lifetime
- 2003-11-12 WO PCT/FR2003/003349 patent/WO2004048375A1/fr active Application Filing
- 2003-11-12 CN CN2003801088984A patent/CN1738817B/zh not_active Expired - Fee Related
- 2003-11-12 US US10/536,028 patent/US7582640B2/en active Active
- 2003-11-12 KR KR1020057009101A patent/KR101140752B1/ko active IP Right Grant
- 2003-11-12 CA CA2506310A patent/CA2506310C/fr not_active Expired - Lifetime
- 2003-11-12 DK DK09003174.1T patent/DK2070914T3/da active
- 2003-11-12 DE DE60327712T patent/DE60327712D1/de not_active Expired - Lifetime
- 2003-11-12 ES ES03799611T patent/ES2325616T3/es not_active Expired - Lifetime
- 2003-11-12 AU AU2003299330A patent/AU2003299330B2/en not_active Ceased
- 2003-11-12 RU RU2005119163/04A patent/RU2412185C2/ru not_active Application Discontinuation
- 2003-11-12 SI SI200332048T patent/SI2070914T1/sl unknown
- 2003-11-12 JP JP2004554592A patent/JP4567459B2/ja not_active Expired - Fee Related
- 2003-11-12 BR BR0316307-5A patent/BR0316307A/pt not_active IP Right Cessation
- 2003-11-13 TW TW092131850A patent/TW200412969A/zh unknown
- 2003-11-18 AR ARP030104254A patent/AR042068A1/es unknown
-
2005
- 2005-04-07 ZA ZA200502850A patent/ZA200502850B/en unknown
- 2005-04-19 IL IL168136A patent/IL168136A/en active IP Right Grant
- 2005-05-12 MA MA28281A patent/MA27492A1/fr unknown
- 2005-05-16 CO CO05046617A patent/CO5700761A2/es not_active Application Discontinuation
- 2005-05-23 NO NO20052491A patent/NO20052491D0/no not_active Application Discontinuation
- 2005-11-03 HK HK05109816.8A patent/HK1076277A1/xx not_active IP Right Cessation
-
2008
- 2008-10-03 US US12/245,622 patent/US7763621B2/en not_active Expired - Fee Related
-
2009
- 2009-07-03 HK HK09106005.1A patent/HK1129372A1/xx not_active IP Right Cessation
- 2009-08-24 AU AU2009212779A patent/AU2009212779B2/en not_active Ceased
-
2010
- 2010-05-11 IL IL205693A patent/IL205693A/en active IP Right Grant
- 2010-07-15 AR ARP100102568A patent/AR077476A2/es not_active Application Discontinuation
-
2011
- 2011-11-02 CY CY20111101051T patent/CY1112218T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1112218T1 (el) | Νεα παραγωγα ανταγωνιστες υποδοχεα βιτρονεκτινης, μεθοδος παρασκευης τους, η εφαρμογη τους ως φαρμακα και φαρμακευτικες συνθεσεις που τα περιεχουν | |
DE60140814D1 (de) | N-phenyl-2-pyrimidine-amine derivatives | |
CY1110332T1 (el) | Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους | |
CY1111705T1 (el) | Παραγωγα 2-αζα-δικυκλο[3.1.0]εξανιου ως ανταγωνιστες του υποδοχεα ορεξινης | |
NO20080670L (no) | Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister | |
HRP20050933A2 (en) | Organic compounds | |
CY1111747T1 (el) | 8-αζαδικυκλο[3.2.1]οκτανο ενωσεις ως ανταγωνιστες μ-οπιοειδους υποδοχεα | |
CY1113639T1 (el) | Παραγωγα βενζαμιδιου και ετεροαρενιου | |
ATE459619T1 (de) | Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung | |
CY1116183T1 (el) | Πιπεραζινοδιονες ως ανταγωνιστες υποδοχεα οξυτοκινης | |
CY1108378T1 (el) | 4-υποκατεστημενα παραγωγα 1-αμινοκυκλοεξανιου για την χρησιμοποιηση σαν προσδεματα υποδοχεα orl1 ή οπιακου υποδοχεα mu | |
BR0306870A (pt) | Composição farmacêutica oral, e, método para preparar a mesma | |
CY1109787T1 (el) | Ανταγωνιστες υποδοχεα γλυκογονου, παρασκευη και θεραπευτικες χρησεις | |
ECSP045367A (es) | "derivados de bencimidazol utiles como antagonistas de histamina h3" | |
SE0401345D0 (sv) | Therapeutic compounds: Pyridine as scaffold | |
SE0401342D0 (sv) | Therapeutic compounds | |
ATE473961T1 (de) | Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung | |
AR054508A1 (es) | Compuesto de bencilpiperazina, su uso para preparar un medicamento, procedimientos para la preparacion de dicho compuesto y de compuestos intermediarios, dichos compuestos intermediarios, composicion farmaceutica que lo comprende y procedimiento para prepararla | |
SE0301701D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
DE60322680D1 (de) | Opioid-rezeptor-aktive 4-(3-hydroxyphenyl) oder 4-(3-alkoxyphenyl)-1,2,4-triazol-verbindungen | |
SE0301699D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
CY1109371T1 (el) | Παραγωγα σουλφαμικου βενζοθειοφαινιου ως αναστολεις σουλφατασης στεροειδους | |
ATE523488T1 (de) | Histamin-h3-rezeptor-mittel, deren herstellung und therapeutische verwendung | |
NO20080669L (no) | Acetylenpiperaziner som metabotrofiske glutamatreseptorantagonister | |
TR200301553A1 (tr) | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar |